111 related articles for article (PubMed ID: 25832834)
1. [Application of radioisotopes for theranostics, a combination of diagnostics and therapy].
Saji H
Yakugaku Zasshi; 2015; 135(4):551-6. PubMed ID: 25832834
[TBL] [Abstract][Full Text] [Related]
2. Neutron-activated theranostic radionuclides for nuclear medicine.
Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
[TBL] [Abstract][Full Text] [Related]
3. [Application of radiometallic compounds for medical diagnosis and therapy].
Saji H
Yakugaku Zasshi; 2008 Mar; 128(3):323-32. PubMed ID: 18311050
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide-Activated Nanomaterials and Their Biomedical Applications.
Ferreira CA; Ni D; Rosenkrans ZT; Cai W
Angew Chem Int Ed Engl; 2019 Sep; 58(38):13232-13252. PubMed ID: 30779286
[TBL] [Abstract][Full Text] [Related]
5. Options to meet the future global demand of radionuclides for radionuclide therapy.
Das T; Pillai MR
Nucl Med Biol; 2013 Jan; 40(1):23-32. PubMed ID: 23116551
[TBL] [Abstract][Full Text] [Related]
6. Radionuclide-based theranostics - a promising strategy for lung cancer.
Zhu T; Hsu JC; Guo J; Chen W; Cai W; Wang K
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2353-2374. PubMed ID: 36929181
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
Kairemo KJ; Tenhunen M; Jekunen AP
Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
[TBL] [Abstract][Full Text] [Related]
8. Nuclear imaging in cancer theranostics.
Del Vecchio S; Zannetti A; Fonti R; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):152-63. PubMed ID: 17420716
[TBL] [Abstract][Full Text] [Related]
9. [Use of radionuclides in therapy].
Vucina J; Han R
Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
[TBL] [Abstract][Full Text] [Related]
10. Scandium Radioisotopes-Toward New Targets and Imaging Modalities.
Kilian K; Pyrzyńska K
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005390
[TBL] [Abstract][Full Text] [Related]
11. [The use of radioactive substances in medicine - history and development prospects].
Sheremeta MS; Trukhin AA; Korchagina MO
Probl Endokrinol (Mosk); 2021 Oct; 67(6):59-67. PubMed ID: 35018762
[TBL] [Abstract][Full Text] [Related]
12. Self-irradiation of the blood from selected nuclides in nuclear medicine.
Hänscheid H; Fernández M; Eberlein U; Lassmann M
Phys Med Biol; 2014 Mar; 59(6):1515-31. PubMed ID: 24594901
[TBL] [Abstract][Full Text] [Related]
13. Bremsstrahlung radiation exposure from pure beta-ray emitters.
Zanzonico PB; Binkert BL; Goldsmith SJ
J Nucl Med; 1999 Jun; 40(6):1024-8. PubMed ID: 10452321
[TBL] [Abstract][Full Text] [Related]
14. Theranostics: combining imaging and therapy.
Kelkar SS; Reineke TM
Bioconjug Chem; 2011 Oct; 22(10):1879-903. PubMed ID: 21830812
[TBL] [Abstract][Full Text] [Related]
15. An alternate approach to the production of radioisotopes for nuclear medicine applications.
D'Auria JM; Keller R; Ladouceur K; Lapi SE; Ruth TJ; Schmor P
Rev Sci Instrum; 2013 Mar; 84(3):034705. PubMed ID: 23556835
[TBL] [Abstract][Full Text] [Related]
16. [Trends of Radiotheranostics Research].
Hosono M
Gan To Kagaku Ryoho; 2022 Aug; 49(8):809-812. PubMed ID: 36046961
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
18. Magnetically enhanced radionuclide therapy.
Raylman RR; Wahl RL
J Nucl Med; 1994 Jan; 35(1):157-63. PubMed ID: 8271038
[TBL] [Abstract][Full Text] [Related]
19. Radiometals for imaging and theranostics, current production, and future perspectives.
Mikolajczak R; van der Meulen NP; Lapi SE
J Labelled Comp Radiopharm; 2019 Aug; 62(10):615-634. PubMed ID: 31137083
[TBL] [Abstract][Full Text] [Related]
20. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
